Genoscience Pharma receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma

View Larger Image

Genoscience Pharma, supported by MATWIN in 2021, receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma.

Download the press release :

stephanie.dhont2023-02-01T14:21:34+01:00